Navigation Links
7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
Date:3/5/2012

(Baton Rouge, March 5, 2012) The International Rett Syndrome Foundation (IRSF) has named local resident Kathryn Schanen Kissam as Chair of the 7th World Congress for Rett Syndrome. The World Congress will consist of four interconnected meetings targeting researchers, clinicians, medical professionals and families impacted by Rett syndrome. These meetings include a Family Education Conference and a Science Symposium co-chaired by renowned Howard Hughes Medical Institute researchers Huda Zoghbi, M.D., Baylor College of Medicine and Director of the Jan and Dan Duncan Neurological Institute and Gail Mandel, Ph.D. Vollum Institute, Oregon Health and Science University.

"The objective of the World Congress is to accelerate treatments and a cure of Rett syndrome and related disorders by stimulating and accelerating novel global research and establishing current standards of care and I'm truly honored to be named Chair." said Kissam. "Families affected by Rett syndrome across the globe need access to the tools and knowledge necessary to improve health and quality of life," she said. Kissam has served as Chairman of IRSF since 2003.

Louisiana's First Lady Supriya Jindal joined Kissam in welcoming the World Congress to Louisiana saying, "We are delighted that New Orleans has been selected as the first United States host city for the 7th World Congress on Rett syndrome. I'm honored to welcome many of the world's most prominent Rett syndrome professionals to our state to uncover ways to benefit families affected by Rett and many other related neurological conditions."

IRSF is holding the World Congress in the U.S. for the first time. Previous sites have included Paris, Ottawa, Vienna and Tokyo.


'/>"/>

Contact: Paige Nues
pnues@rettsyndrome.org
510-499-3858
International Rett Syndrome Foundation
Source:Eurekalert

Page: 1

Related biology news :

1. UMD and Chinese partner to track and predict world climate change
2. Researchers develop worlds first biodegradable joint implant
3. World nourishment at risk of being diminished: Wild cereals threatened by global warming
4. Press registration open for World Series of Science
5. Window into worlds future oceans unveiled by NF-UBC Nereus team
6. Revealed in accurate detail, the underground world of plants
7. Worlds top technology researchers coming to Queens for TEI 2012
8. Worlds greenest supercomputer heads to Melbourne to boost health research
9. World class to second class? Confronting the risks to US science and innovation
10. Are nuisance jellyfish really taking over the worlds oceans?
11. Satellite study reveals critical habitat and corridors for worlds rarest gorilla
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/15/2014)... The Ebola virus is spreading rapidly and to an ... experienced in the past and the virus shows a ... been recorded before. For this reason, the German National ... of Science and Engineering, and the Union of the ... statement on the Ebola epidemic today. , In the ...
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology ... today announced the availability of the VeriLook ... Surveillance 3.0 provides real-time biometric face identification using ... digital surveillance cameras. The new version not only ... differentiates people from objects while they are moving ...
(Date:10/14/2014)... fly genome for the first time, revealing robust immune ... thrives in pathogen-rich dung piles and garbage heaps. , ... Genome Biology , will increase understanding of house fly ... to resist insecticides, which could lead to novel control ... transmit more than 100 human and animal diseases, including ...
Breaking Biology News(10 mins):Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3House fly genome reveals expanded immune system 2
... awarded two Clemson chemistry faculty nearly $1 million to ... McNeill and Ken Christensen will receive the $960,000 grant ... in live cells. The development of techniques for ... could use this technology to determine the bodys defenses ...
... Mo. Heart disease is the leading cause of ... quality and length of life for individuals with specific ... gene and/or stem cell therapy could help a variety ... have been unsure whether the heart could benefit from ...
... the superhero cure for viral infections, may be ... infections in immunocompromised patients, according to an article ... Fungal infections (mycoses) were once seen as exotic ... life-threatening in healthy patients, fungal infections are a ...
Cached Biology News:NIH recognizes Clemson nanotechnology for molecule tracking 2Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart 2Gamma interferon could aid fight against fungal infections 2
(Date:10/22/2014)... , Oct. 22, 2014 Nuvilex, Inc. (OTCQB: ... 400 million people worldwide are living with diabetes, with  ... by 2030.  The global market for diabetes treatments is ... 330,000 people worldwide died from pancreatic cancer.  Pancreatic cancer ... to cancer in the United States ...
(Date:10/20/2014)... Convey Computer , the leader ... Iowa State University won first place in the ... HC-2ex, the team’s solution achieved the highest overall performance ... second place finisher. , Experts from all segments of ... long challenge, using a variety of design tools, hardware ...
(Date:10/20/2014)... , Oct. 20, 2014 PureTech ... company tackling big healthcare problems, announced today the ... round, with participation from Invesco Perpetual, a $120 ... used to drive PureTech,s existing pipeline forward and ... "PureTech has the scientific creativity to really go ...
(Date:10/19/2014)... OCTOBER 20-22, 2014: The 9th Annual ... take place at the Congress Center Basel, ... now available at http://www.abim.ch . ... from all over the globe will exchange ... products and developments on the world market. ...
Breaking Biology Technology:Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6
... Capabilities ... & Team, CANTON, Mass. and BATON ROUGE, ... successful regenerative medicine,company, announced today the strategic acquisition ... develops "designer scaffolds" for the,purposes of regenerative medicine, ...
... RESEARCH TRIANGLE PARK, N.C., Feb. 25 ... tools for signal,transduction analysis, announced today that ... flagmanship technology, the FACTORIAL(TM). In,advance online publication ... colleagues describes a novel and remarkably consistent ...
... Feb. 25 Alexza,Pharmaceuticals, Inc. (Nasdaq: ... initiated,its first Phase 3 clinical trial with ... candidate being developed for the treatment of,acute ... disorder. Alexza,believes the novel, non-invasive nature and ...
Cached Biology Technology:Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc. 2Organogenesis, Inc. Announces Acquisition of NanoMatrix, Inc. 3Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 2Attagene's Breakthrough Transcription Factor Profiling Technology to be Described in Nature Methods 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 2Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 3Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 4Alexza Initiates First Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine) 5
Request Info...
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
Detect and measure levels of mouse IgG3 antibody isotypes quickly and easily....
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Biology Products: